Biohaven Gains As SK Biopharma Licenses Kv7 Epilepsy Platform In Global Deal
(RTTNews) - Biohaven Ltd. (BHVN), a biopharmaceutical company, on Wednesday announced a global licensing agreement with SK Biopharmaceuticals Co., Ltd. (326030.KS).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.